ES2365028T3 - Uso de complejos de galio(iii) para el tratamiento de melanomas. - Google Patents

Uso de complejos de galio(iii) para el tratamiento de melanomas. Download PDF

Info

Publication number
ES2365028T3
ES2365028T3 ES07701315T ES07701315T ES2365028T3 ES 2365028 T3 ES2365028 T3 ES 2365028T3 ES 07701315 T ES07701315 T ES 07701315T ES 07701315 T ES07701315 T ES 07701315T ES 2365028 T3 ES2365028 T3 ES 2365028T3
Authority
ES
Spain
Prior art keywords
compound according
alkyl
cycloalkyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07701315T
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Keppler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niiki Pharma Inc
Original Assignee
Niiki Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niiki Pharma Inc filed Critical Niiki Pharma Inc
Application granted granted Critical
Publication of ES2365028T3 publication Critical patent/ES2365028T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
ES07701315T 2006-02-13 2007-02-13 Uso de complejos de galio(iii) para el tratamiento de melanomas. Active ES2365028T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA220/2006 2006-02-13
AT0022006A AT503317B1 (de) 2006-02-13 2006-02-13 Verwendung von gallium(iii)-komplexen zur herstellung eines medikaments zur behandlung von melanomen

Publications (1)

Publication Number Publication Date
ES2365028T3 true ES2365028T3 (es) 2011-09-20

Family

ID=37969931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07701315T Active ES2365028T3 (es) 2006-02-13 2007-02-13 Uso de complejos de galio(iii) para el tratamiento de melanomas.

Country Status (12)

Country Link
US (1) US7919486B2 (cg-RX-API-DMAC7.html)
EP (1) EP1984005B1 (cg-RX-API-DMAC7.html)
JP (1) JP5210888B2 (cg-RX-API-DMAC7.html)
CN (1) CN101466387A (cg-RX-API-DMAC7.html)
AT (2) AT503317B1 (cg-RX-API-DMAC7.html)
AU (1) AU2007215363A1 (cg-RX-API-DMAC7.html)
CA (1) CA2640509C (cg-RX-API-DMAC7.html)
DE (1) DE502007006880D1 (cg-RX-API-DMAC7.html)
ES (1) ES2365028T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ571119A (cg-RX-API-DMAC7.html)
PT (1) PT1984005E (cg-RX-API-DMAC7.html)
WO (1) WO2007092978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101783676B1 (ko) * 2010-02-12 2017-10-10 니키 파머 액퀴지션 코포레이션 2 혈액암의 치료 방법
JP2013521229A (ja) * 2010-02-26 2013-06-10 ニッキ ファーマ インク. 脳腫瘍を処置するための方法
CN102946879B (zh) 2010-04-19 2015-04-22 尼基制药公司 一种蛋白酶体抑制剂和镓络合物在制备治疗增殖性疾病的药物中的应用
JP6112512B2 (ja) * 2010-12-01 2017-04-12 レクシ ファーマ インコーポレイテッド 難治性癌を治療するための方法
CN113372269A (zh) * 2021-06-25 2021-09-10 云南大学 一种席夫碱镓配合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE166056T1 (de) * 1991-07-25 1998-05-15 Philippe Collery Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
DE10116527C2 (de) * 2001-04-03 2003-05-15 Faustus Forschungs Cie Tumorhemmende Galliumverbindungen, deren Verwendung als Arzneimittel sowie ein Arzneimittel, diese enthaltend
AT501819B1 (de) * 2005-04-18 2007-01-15 Faustus Forschung Translationa Verwendung von gallium(iii)-komplexen zur behandlung von tumorerkrankungen der leber

Also Published As

Publication number Publication date
US20090137620A1 (en) 2009-05-28
NZ571119A (en) 2011-11-25
PT1984005E (pt) 2011-07-11
AU2007215363A1 (en) 2007-08-23
CA2640509A1 (en) 2007-08-23
DE502007006880D1 (de) 2011-05-19
EP1984005B1 (de) 2011-04-06
JP2009525987A (ja) 2009-07-16
CA2640509C (en) 2014-07-08
WO2007092978A1 (de) 2007-08-23
AT503317A4 (de) 2007-09-15
EP1984005A1 (de) 2008-10-29
US7919486B2 (en) 2011-04-05
CN101466387A (zh) 2009-06-24
ATE504307T1 (de) 2011-04-15
AT503317B1 (de) 2007-09-15
JP5210888B2 (ja) 2013-06-12

Similar Documents

Publication Publication Date Title
AU2020253385B2 (en) Hsp90-binding conjugates and formulations thereof
ES2367028T3 (es) Composiciones sinérgicas con fk-228.
ES2287495T3 (es) Forma polimorfa cristalina de clorhidrato de irinotecan.
ES2911430T3 (es) Composiciones que comprenden una fuente de metal, ditiocarbamato y ciclodextrina
ES2405323T3 (es) Tratamiento de melanoma
ES2441593T3 (es) Composiciones para estimular la actividad de terapias anticáncer
ES2273841T3 (es) Combinacion sinergica para el tratamiento de cancer colorrectal.
ES2319258T3 (es) Complejos de platino como agentes antitumorales.
ES2414617T3 (es) Ácidos grasos de cadena de longitud media, sales y triglicéridos en combinación con gemcitabina para el tratamiento del cáncer pancreático
US20050032801A1 (en) Compositions containing a ruthenium(III) complex and a heterocycle
US7919486B2 (en) Use of gallium(III) complexes for the treatment of melanomas
ES2414861T3 (es) Uso del FTS para el tratamiento de trastornos malignos
ES2746946T3 (es) Combinación de alisertib y paclitaxel para el tratamiento de cáncer
ES2991018T3 (es) (N-(2-((2-bencilfenil)amino)-2-oxoetil)-L-naftamida) como agente terapéutico anticanceroso
ES2284061T3 (es) Procedimiento para la produccion de sales y derivados de trans- o cis-diamoniodiclorodihidroxoplatino (iv) y su uso para la produccion de principios activos farmaceuticos.
ES2896051T3 (es) Fármaco antitumoral que contiene un complejo de platino antitumoral y un potenciador del efecto antitumoral
CN104744518B (zh) 金属钌配合物及其制备方法和应用
CN108498518B (zh) 七元环小檗碱类似物及其药物组合物在制备治疗多发性骨髓瘤的药物中的应用
AU769882B2 (en) Medicament containing platinum complex compounds and the use thereof
PT793667E (pt) Complexos trinucleares platina cationica com actividade antitumor e composicoes farmaceuticas que os contem
CN104606189B (zh) 一种化合物在制备mTOR抑制剂中的应用
CN111494371B (zh) Pyr3的用途
AU2013206221A1 (en) Use of gallium (III) complexes for the treatment of melanomas
ES2930009T3 (es) Métodos para el cáncer e inmunoterapia con análogos de glutamina, comprendiendo deoxinivalenol DON incluido
WO2022265829A1 (en) Synthetic cellular membrane chemical ionophore delivery system comprising hexa-aqua ligand compositions